Journal of Clinical Endocrinology & Metabolism, Vol 63, 376-382, Copyright © 1986 by Endocrine Society

ARTICLES

Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty

JP Bourguignon, M Vandeweghe, M Vanderschueren-Lodeweyckx, P Malvaux, R Wolter, M Du Caju and C Ernould

Twenty-two hypopituitary boys treated with human GH were studied longitudinally before and during puberty. Eight patients entered spontaneous puberty at a mean bone age of 12.4 +/- 1.0 (+/- SD) yr. Height velocity reached a mean peak of 6.8 cm/yr during the second year of spontaneous puberty. In these patients, the mean total height gain throughout puberty was 22.8 +/- 5.2 cm, and the mean final height was 158.6 +/- 7.2 cm. Fourteen patients received testosterone enanthate (100 mg/month, im) starting at a mean bone age of 13.6 +/- 1.1 yr. Height velocity was maximal (7.5 cm/yr) during the first year of therapy. The mean final height was 162.9 +/- 5.0 cm, with a mean pubertal gain of 15.9 +/- 3.8 cm. Genital development, peak height velocity, and increase in plasma testosterone levels occurred earlier during testosterone therapy than during spontaneous puberty. In both groups of patients, there was a positive correlation between the bone age at onset of puberty and the height at onset of puberty (r = 0.65). There was also a negative correlation between bone age and total pubertal height gain (r = -0.73). This reduction in pubertal height increase was less than expected for bone age at onset of puberty, which can be explained by a decrease in bone age velocity in relation to bone age at onset of puberty (r = -0.81). Therefore, advancement in bone age at the onset of testosterone therapy did not impair final height, whereas it may increase height at onset of puberty, which is the major factor in final height. We conclude that in GH- and gonadotropin- deficient boys 1) a reduced dosage of testosterone enanthate (25 mg twice a month, im) should be used to induce pubertal development, and 2) the major criterion to decide when to give testosterone is height reached at that time regardless of bone age.

This article has been cited by other articles:

				M. Maghnie, L. Ambrosini, M. Cappa, G. Pozzobon, L. Ghizzoni, M. G. Ubertini, N. di Iorgi, C. Tinelli, S. Pilia, G. Chiumello, et al. Adult Height in Patients with Permanent Growth Hormone Deficiency with and without Multiple Pituitary Hormone Deficiencies J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2900 - 2905. [Abstract] [Full Text] [PDF]

				A. A. L. Jorge, F. G. Marchisotti, L. R. Montenegro, L. R. Carvalho, B. B. Mendonca, and I. J. P. Arnhold Growth Hormone (GH) Pharmacogenetics: Influence of GH Receptor Exon 3 Retention or Deletion on First-Year Growth Response and Final Height in Patients with Severe GH Deficiency J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1076 - 1080. [Abstract] [Full Text] [PDF]

				M. B. Ranke, A. Lindberg, D. D. Martin, B. Bakker, P. Wilton, K. Albertsson-Wikland, C. T. Cowell, D. A. Price, and E. O. Reiter The Mathematical Model for Total Pubertal Growth in Idiopathic Growth Hormone (GH) Deficiency Suggests a Moderate Role of GH Dose J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4748 - 4753. [Abstract] [Full Text] [PDF]

				G A Kamp, J J J Waelkens, S M P F de Muinck Keizer-Schrama, H A Delemarre-Van de Waal, L Verhoeven-Wind, A H Zwinderman, J M Wit, and P E Clayton High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature Arch. Dis. Child., September 1, 2002; 87(3): 215 - 220. [Abstract] [Full Text] [PDF]

				W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet Optimizing GH Therapy in Adults and Children Endocr. Rev., August 1, 2001; 22(4): 425 - 450. [Abstract] [Full Text] [PDF]

				G. Saggese, G. Federico, S. Barsanti, and L. Fiore The Effect of Administering Gonadotropin-Releasing Hormone Agonist with Recombinant-Human Growth Hormone (GH) on the Final Height of Girls with Isolated GH Deficiency: Results from a Controlled Study J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1900 - 1904. [Abstract] [Full Text]

				J. P. Frindik and J. Baptista Adult Height in Growth Hormone Deficiency: Historical Perspective and Examples From the National Cooperative Growth Study Pediatrics, October 1, 1999; 104(4): 1000 - 1004. [Abstract] [Full Text]

				M. B. Ranke, A. Lindberg, P. Chatelain, P. Wilton, W. Cutfield, K. Albertsson-Wikland, and D. A. Price Derivation and Validation of a Mathematical Model for Predicting the Response to Exogenous Recombinant Human Growth Hormone (GH) in Prepubertal Children with Idiopathic GH Deficiency J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1174 - 1183. [Abstract] [Full Text]

				G. Maor, Y. Segev, and M. Phillip Testosterone Stimulates Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-I-Receptor Gene Expression in the Mandibular Condyle--A Model of Endochondral Ossification Endocrinology, April 1, 1999; 140(4): 1901 - 1910. [Abstract] [Full Text]

				J. K. Rao, J. R. Julius, T. J. Breen, and S. L. Blethen Response to Growth Hormone in Attention Deficit Hyperactivity Disorder: Effects of Methylphenidate and Pemoline Therapy Pediatrics, August 1, 1998; 102(2): 497 - 500. [Abstract] [Full Text]

				G. P. August, J. R. Julius, and S. L. Blethen Adult Height in Children With Growth Hormone Deficiency Who Are Treated With Biosynthetic Growth Hormone: The National Cooperative Growth Study Experience Pediatrics, August 1, 1998; 102(2): 512 - 516. [Abstract] [Full Text]

				S. L. Blethen, J. Baptista, J. Kuntze, T. Foley, S. LaFranchi, and A. Johanson Adult Height in Growth Hormone (GH)-Deficient Children Treated with Biosynthetic GH J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 418 - 420. [Abstract] [Full Text] [PDF]

				R. Rappaport, E. Mugnier, C. Limoni, H. Crosnier, P. Czernichow, J. Leger, J.-M. Limal, P. Rochiccioli, and S. Soskin A 5-Year Prospective Study of Growth Hormone (GH)-Deficient Children Treated with GH before the Age of 3 Years J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 452 - 456. [Abstract] [Full Text] [PDF]